Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pelthos Therapeutics (PTHS) Long-Term Debt Repayments (2024 - 2025)

Pelthos Therapeutics has reported Long-Term Debt Repayments over the past 2 years, most recently at $1.7 million for Q4 2025.

  • Quarterly results put Long-Term Debt Repayments at $1.7 million for Q4 2025, up 293.02% from a year ago — trailing twelve months through Dec 2025 was $2.1 million (up 885.93% YoY), and the annual figure for FY2025 was $845000.0, up 293.02%.
  • Long-Term Debt Repayments for Q4 2025 was $1.7 million at Pelthos Therapeutics, up from $430000.0 in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for PTHS hit a ceiling of $1.7 million in Q4 2025 and a floor of -$214757.0 in Q1 2024.